High-efficiency adsorption removal of CR and MG dyes using AlOOH fibers embedded with porous CoFe2O4 nanoparticles.

Owing to the toxicity and difficulty in degradation, how to the effective separation for the residual dyes in the aqueous solution is still an issue with great challenge in the area of environmental protection. Now, to high-efficiency removal of organic dyes from the aqueous solution, we design a unique AlOOH/CoFe2O4 adsorbent with porous CoFe2O4 nanoparticles embedded on the AlOOH fibers using a simple hydrothermal technique and calcination process. The structural properties and surface characteristics of the AlOOH/CoFe2O4 composites are detailedly analyzed by XRD, FTIR, XPS, TEM and SEM. Here, the high SBET and specific porous structure are beneficial to improve the adsorption performance of AlOOH/CoFe2O4 adsorbents. Especially, when the molar ratio of AlOOH to CoFe2O4 in the AlOOH/CoFe2O4 fibers is 1:1, an optimal performance on adsorbing anionic Congo red (CR) and cationic methyl green (MG) dyes can be obtained at pH = 6.29, where the corresponding maximum adsorption capacities reach up to 565.0 and 423.7 mg g-1, respectively. Factors leading to the change in the ability of adsorbing CR and MG dyes are systematically discussed, including contact time, temperature, initial concentrations, and pH values of the solutions. Meanwhile, the uptake of CR and MG dyes can best conform to Langmuir isotherm model and pseudo-second-order adsorption kinetics. The thermodynamic analysis verifies that the dye adsorption process is spontaneous and endothermic. Moreover, from the point view of practical application, the good reusability further makes the as-synthesized magnetic AlOOH/CoFe2O4 composite be a perfect adsorbent with efficiently removing both anionic and cationic dyes from aqueous solutions.

A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment.

Immunotherapy has ushered in a new era of cancer therapy, and this is also applicable to therapy of hepatocellular carcinoma (HCC). In this context, effective development of therapeutic strategies requires an HCC mouse model with known tumor-associated antigens (TAAs) and an HCC growth reporter. We created such a model using hydrodynamic injection and a transposon system to introduce AKT and NRAS and open reading frames (ORFs) encoding surrogate tumor antigens and luciferase into chromosomes of hepatocytes to induce nodular and diffuse tumors in the liver. TAA-specific CD8+ T cells were detected during HCC progression; however, these showed exhausted-like phenotypes and were unable to control tumor growth. Myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAM) from the tumor microenvironment were found to contribute to the suppression of the CD8+ T-cell response. The transposon-based Akt/N-Ras-induced HCC mouse model we developed enables researchers to monitor tumor growth non-invasively and to quantify and characterize endogenous or adoptively transferred TAA-specific CD8+ T-cell responses. These features make it a suitable preclinical model for exploration and evaluation of immune checkpoint inhibitors and cell-based immunotherapies for HCC treatment.